Steroid 11 beta-hydroxylase mutant recombinant bacterium Aspergillus niger and application thereof in preparation of hydrocortisone

By applying CRISPR-Cas9 editing technology and semi-rational design in Aspergillus niger, the highly hydroxylated specific C11β-hydroxylase mutant T291Y/M365A was obtained, which solved the low feed volume and secondary feeding in the existing hydrocortisone production. The problem of many products has achieved efficient and safe hydrocortisone production.

CN118979019APending Publication Date: 2024-11-19TIANJIN UNIV OF SCI & TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411283946.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-13
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

The existing hydrocortisone production process has problems with low feed volume, many by-products, low specificity and potential pathogenicity of Sporidium crescent. It is necessary to improve the C11β-hydroxylase gene to improve hydroxylation specificity and safety. sex.

Method used

Through semi-rational design and CRISPR-Cas9 editing technology, the highly hydroxylated specific C11β-hydroxylase mutant T291Y/M365A was obtained and introduced into Aspergillus niger to construct a recombinant strain that efficiently prepares hydrocortisone. CRISPR-Cas9 editing used Aspergillus niger with CYP65 and CYP5061 functions as hosts and replaced the C11β-hydroxylase gene to improve production efficiency.

Benefits of technology

It significantly improves the hydroxylation specificity and production efficiency of hydrocortisone, reduces the generation of by-products, and provides a safe and efficient production solution, replacing the use of traditional crolizuli.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118979019A_ABST
    Figure CN118979019A_ABST
Patent Text Reader

Abstract

The invention discloses a novel method for efficiently preparing hydrocortisone by using recombinant aspergillus niger, and belongs to the technical field of gene engineering. According to the invention, an aspergillus niger chassis strain suitable for expressing exogenous hydroxylase is obtained through CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats-associated protein 9) editing, and an aspergillus niger recombinant bacterium for efficiently and heterologously expressing the curvularia lunata 11 beta-hydroxylase CYP5103B6 T291Y / M365A mutant is constructed. 11-deoxycorticolin-21 acetate is used as a substrate, the feeding amount is 4.5 g / L, conversion is carried out for 72 h, the specificity can reach 91.3%, and the yield of hydrocortisone is 82.6%. The invention provides a technical method and a valuable industrial strain for researching and developing a process for producing the hydrocortisone by using the efficient C11 beta-hydroxylase gene recombinant strain.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of genetic engineering, and specifically relates to the construction and application of a 11β-hydroxylase CYP5103B6 mutant recombinant Aspergillus niger. Background Art

[0002] Steroidal compounds are a class of compounds with cyclopentane polyhydrophenanthrene as the basic skeleton, also known as steroids. They have pharmacological activities such as anti-inflammatory, anti-allergic, anti-cancer and contraceptive, and are widely used in rheumatism, endocrine disorders, contraception, etc. At present, the main methods for modifying the structure of steroids are microbial transformation and chemical synthesis, or a combination of the two. Due to the shortcomings of the full chemical synthesis method, such as the difficulty in separating by-products and the high cost, the industry often uses microbial transformation to introduce key functional groups at specific positions of steroids.

[0003] Hydrocortisone (11β, 17α, 21-trihydroxypregnane-4-ene-3, 20-dione) is a glucocorticoid with anti-toxic, anti-inflammatory, and immunosuppressive effects. Currently, hydrocortisone (HC) is generally produced in industry through Curvularia lunulata. The specific reaction is that 11-deoxycortisol-21-acetate (RSA) is hydrolyzed to obtain 11-deoxycortisol (RS), and then RS is hydroxylated by C11β-hydroxylase to generate HC, such as Figure 1 However, the existing production process has the disadvantages of low feed amount, many by-products, low specificity, etc., and the crescent spore has a certain potential pathogenicity, and it is not considered to be a completely safe strain. Therefore, it is necessary to modify the C11β-hydroxylase gene and replace the appropriate host bacteria.

[0004] Aspergillus niger is a filamentous fungus that is ubiquitous in the environment and is often used in food and drug production processes. It is an ideal and safe host strain for heterologous protein expression and an important filamentous fungal expression system.

[0005] In order to improve the hydroxylation specificity of C11β-hydroxylase CYP5103B6 from Curvularia lunulae to the substrate 11-deoxycortisol (RS) and reduce byproducts, our laboratory has used rational design to molecularly transform C11β-hydroxylase CYP5103B6, and screened a recombinant strain of Saccharomyces cerevisiae with a C11β-hydroxylase mutant T291Y / M365A with high hydroxylation specificity, and its hydroxylation specificity is significantly improved. The present invention introduces the C11β-hydroxylase mutant gene CYP5103B6T291Y / M365A into the modified Aspergillus niger chassis to develop a highly efficient recombinant strain for producing hydrocortisone. Summary of the invention

[0006] In view of the current situation that the specificity of hydrocortisone producing strains is not high, the present invention uses genetic engineering molecular manipulation technology to obtain a recombinant Aspergillus niger with significantly reduced background impact of transformation of the recombinant Aspergillus niger and constructs a recombinant expression vector of the C11β-hydroxylase gene mutant CYP5103B6T291Y / M365A with high hydroxylation specificity.

[0007] The technical route of the invention is as follows: the laboratory identified the C11β-hydroxylase gene CYP5103B6 of Curvularia lunata in the early stage, and transformed it by semi-rational design and site-directed mutagenesis technology, and obtained the mutant T291Y / M365A with high hydroxylation specificity and the recombinant Saccharomyces cerevisiae strain. In order to further increase the feed amount and improve the process efficiency, the present invention obtains Aspergillus niger with CYP65 and CYP5061 functional deficiency by CRISPR-Cas9 editing, and then replaces the functional deficiency of Aspergillus niger middle chassis strain with C11βv hydroxylase gene CYP5103B6T291Y / M365A by CRISPR-Cas9 editing, and obtains an industrially efficient Aspergillus niger recombinant bacteria for preparing hydrocortisone, which provides a reference for the C11β-hydroxylation process.

[0008] (1) Determine the CYP5103B6 gene sequence targeted by Cas9;

[0009] (2) constructing the expression vector pAMA1-gRNA-1-2-Cas9 containing two gRNA expression cassettes, one Cas9 expression cassette and the AMA1 sequence;

[0010] (3) introducing the recombinant expression vector in (2) into Aspergillus niger by protoplast transformation and co-transformation method for gene editing;

[0011] (4) The 11β-hydroxylase CYP5103B6T291Y / M365A mutant Aspergillus niger recombinant bacteria obtained in (3) were simultaneously spotted onto 300 mg / ml hygromycin B and non-antibiotic PDA plates for screening, and the Aspergillus niger recombinant bacteria that lost the plasmid were screened out.

[0012] (5) extracting the genome of the obtained transformants and performing sequencing verification to obtain the 11β-hydroxylase CYP5103B6T291Y / M365A mutant Aspergillus niger host strain;

[0013] The CYP5103B6 claimed in the present invention is derived from Curvularia lunata.

[0014] The amino acid sequence of the mutant T291Y / M365A of the present invention is shown in SEQ ID NO: 2, and its corresponding nucleotide sequence is shown in SEQ ID NO: 2.

[0015] The chassis strain of the invention is an Aspergillus niger host strain which directionally destroys the steroid 16β-hydroxylase gene CYP65 and the steroid 11α-hydroxylase gene CYP5061.

[0016] The recombinant expression vector, recombinant expression plasmid or host cell constructed by using the gene fragment CYP5103B6 T291Y / M365A encoding C11β-hydroxylase of the present invention also belongs to the protection scope of the present invention, and the amplification primer sequence used also belongs to the protection scope of the present invention.

[0017] The steroid hydroxylase encoded by the mutant gene CYP5103B6 T291Y / M365A obtained by site-directed mutagenesis of the present invention includes but is not limited to expression in host cells such as Saccharomyces cerevisiae, Pichia pastoris, and Aspergillus niger.

[0018] Beneficial effects: The present invention utilizes CRISPR-Cas9 technology to transform wild Aspergillus niger ATCC1015, obtains an Aspergillus niger host strain with inactivated C16β-hydroxylase gene CYP65 and C11α-hydroxylase gene CYP5061, and then obtains a recombinant Aspergillus niger for efficiently preparing hydrocortisone through CRISPR-Cas9 technology. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 It is the C11β-hydroxylation reaction of 11-deoxycortisol;

[0020] Figure 2 Schematic diagram of AMAI-gRNA-1-2-Cas9 expression vector;

[0021] Figure 3 Schematic diagram of co-transformation of AMAI--gRNA-1-2-Cas9 and CYP5103B6 T291Y / M365A transformants;

[0022] Figure 4 This is the specificity of recombinant C11β-hydroxylated Aspergillus niger at a feed amount of 4.5 g / L.

[0023] Figure 5 It is the yield of recombinant C11β-hydroxylated Aspergillus niger after transformation for 72 hours at a feed rate of 4.5 g / L. DETAILED DESCRIPTION

[0024] The method of the present invention is described below by specific embodiments. The experimental methods in the following examples are conventional methods unless otherwise specified. The embodiments should be understood to be illustrative rather than limiting the scope of the present invention, and the essence and scope of the present invention are limited only by the claims. The test materials used in the following examples are purchased from conventional biochemical reagent stores unless otherwise specified.

[0025] The present invention relates to strains: Escherichia coli (Escherichiacoli JM109), Aspergillus niger ATCC1015 (Aspergillus niger ATCC1015).

[0026] Example 1. Construction of Aspergillus niger chassis strains with CRISPR-Cas9 directed disruption of steroid C16β-hydroxylase gene CYP65 and steroid 11α-hydroxylase gene CYP5061

[0027] 1.1 Determination of Cas9-targeted CYP65 and CYP5061 gene sequences

[0028] Target-1:TCTGGAACATCTATTTGCAT

[0029] Target-2:ATGCAAATAGATGTTCCAGA

[0030] Target-3: ACACCTCTTGCAAGGTGTTG

[0031] Target-4: CAACACCTTGCAAGAGGTGT

[0032] 1.2 Construction of pBlue-gRNA-1 and pBlue-gRNA-2 vectors

[0033] The plasmid pBlue-gRNA was used as a template and F / R-CYP65 was used as a primer for polymerase chain reaction to obtain the target vector fragments pBlue-gRNA-1 and pBlue-gRNA-2. The primers were synthesized by Beijing BGI.

[0034] F-CYP65:TCTGGAACATCTATTTGCATGTTTTAGAGCTAGAAATAGCAAG

[0035] R-CYP65:ATGCAAATAGATGTTCCAGAACTTGTTCTTCTTTACAATGATT

[0036] F-CYP5061: ACACCTCTTGCAAGGTGTTGGTTTTAGAGCTAGAAATAGCAAG

[0037] R-CYP5061: CAACACCTTGCAAGAGGTGTACTTGTTCTTCTTTACAATGATT

[0038] 2 μl of PCR product was taken for agarose gel electrophoresis to verify its band size. The PCR product was digested with Dpn I and purified and recovered, and the recovered product was transformed into competent E. coli JM109. The transformant was picked to extract the plasmid and sequenced to verify that it was correct, thus obtaining pBlue-gRNA-1 and pBlue-gRNA-2.

[0039] PCR reaction system (Total 50μl):

[0040]

[0041]

[0042]

[0043] 1.3 Construction of AMAI-gRNA-1-2-Cas9 vector

[0044] The AMAI-Cas9 plasmid was digested with MIU I to prepare a homologous recombination backbone. The pBlue-gRNA-1 and pBlue-gRNA-2 plasmids were used as templates to design primers with homology arms to amplify the target fragment containing the gRNA expression cassette. After digestion and purification, the target fragment and the backbone were homologously recombined. The recombinant system was transformed into Escherichia coli JM109 competent cells. The transformants were picked to extract the plasmids and sequenced to verify that they were correct, thus obtaining the AMAI-gRNA-1-2-Cas9 plasmid. Figure 2 As shown, the primers were synthesized by Beijing BGI Corporation.

[0045] F-U6 box-Mlu1: CAGTGCCAAGCTTAACGCGTCTAATGCCGGCTCATTCAAACG

[0046] R-1-gRNA:GAATGAGCCGGCATTAGAGCAGCTCTATATCACGTGAC

[0047] F-1-gRNA: GTCACGTGATATAGAGCTGCTCTAATGCCGGCTCATTC

[0048] R-U6 cassette-Mlu1-to-pLM1: CAATATCATCTTCTGACGCGAGCAGCTCTATATCACGTGAC

[0049] PCR reaction system (Total 50μl):

[0050]

[0051]

[0052] Enzyme digestion reaction system (Total 50μl):

[0053]

[0054]

[0055] Recombination reaction system (Total 10μl):

[0056]

[0057] 1.4AMAI-gRNA-1-2-Cas9 vector protoplast transformation was used to obtain the recombinant Aspergillus niger ATCC1015 chassis recombinant bacteria with CYP65 and CYP5061 knocked out.

[0058] 3-5 μg of recombinant plasmid AMAI-gRNA-1-2-Cas9 was added to wild Aspergillus niger ATCC1015 protoplasts with a concentration of >108 cells / ml and 680 μl of PEG6000 solution was added, and the mixture was incubated on ice for 20 min.

[0059] Add 2 ml of PEG6000 buffer and place at room temperature for 10 min

[0060] Add 4 ml STC and 4 ml upper culture medium preheated and mixed at 48 °C, and spread on the lower culture medium with hygromycin concentration of 300 mg / ml. Place the plate in a 28 °C incubator. After 5-7 days, transformants will grow. Figure 3 As shown, it was transferred to a PDA test tube containing 300 mg / ml hygromycin and cultured until spores were produced. The spores were washed with sterile water, and the transformation experiment was used to verify that a recombinant strain of Aspergillus niger with destroyed C16β-hydroxylase gene CYP65 and C11α-hydroxylase gene CYP5061 was obtained, and its genome was extracted and confirmed by sequencing.

[0061] Example 2. Construction of pAMAI-CYP5103B6 T291Y / M365A expression vector

[0062] The AMAI-gRNA plasmid was digested with MIUI single enzyme to prepare the homologous recombination backbone. The pCSN44-CYP5103B6 plasmid was used as a template to design primers with homology arms to amplify the CYP5103B6 fragment with TrpC promoter and terminator. After digestion and purification, the target fragment and the backbone were homologously recombined. The recombination system was transformed into Escherichia coli JM109 competent cells, and the transformants were picked to extract the plasmids, which were verified to be correct by sequencing, thus obtaining the AMAI-gRNA-CYP5103B6 plasmid. The primers were synthesized by Beijing BGI Genomics Co., Ltd.

[0063] F-CYP5103B6-to pLM1: CAGTGCCAAGCTTAACGCGTCTTATCGATACCCGTCGAC

[0064] R-CYP5103B6-to pLM1:CTGGCCCCGGGTACGCGGAAAGAAGGATTACCTC

[0065] PCR reaction system (Total 50μl):

[0066]

[0067]

[0068] Enzyme digestion reaction system (Total 50μl):

[0069]

[0070] Recombination reaction system (Total 10μl):

[0071]

[0072]

[0073] Example 3. Construction of C11β mutant recombinant Aspergillus niger

[0074] 3-5 μg of recombinant plasmid pAMA1-gRNA-CYP5103B6 T291Y / M365A was added to the protoplasts prepared by recombinant Aspergillus niger with a concentration of >108 cells / ml and 680 μl of PEG6000 solution was added, and the mixture was incubated on ice for 20 min;

[0075] Add 2 ml of PEG6000 buffer and place at room temperature for 10 min;

[0076] Add 4 ml STC and 4 ml upper culture medium preheated and mixed at 48°C, and spread on the lower culture medium with hygromycin concentration of 300 mg / ml. Place the plate upright in a 28°C incubator. After 5-7 days, wait for transformants to grow and verify by subculture.

[0077] Example 4. Substrate transformation of C11β mutant recombinant Aspergillus niger

[0078] The feed amount of substrate RSA (11-deoxycortisol-21-acetate) was 4.5 g / L, and the C11β mutant recombinant Aspergillus niger was used for steroid transformation experiment. The spore suspension was cultured in a shaking table at 28°C for 24 hours before the substrate was added. The fermentation conversion was sampled for 24 hours / 48 hours / 72 hours, and extracted with ethyl acetate. Figure 4 It can be seen that its specificity is as follows. Figure 5 shown.

[0079] The above embodiments only express several implementation methods of the present invention, but they are not intended to limit the present invention. It should be noted that any person skilled in the art can make several improvements to the above implementation methods without departing from the spirit and scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the content defined in the claims.

Claims

1. Steroid 11β-hydroxylase gene mutant T291Y / M365A It is characterized in that The amino acid sequence of the mutant is mutated on the basis of the sequence shown in SEQ ID NO: 1, that is, the amino acid at position 291 of the mutant is changed from the original threonine (ACC) to leucine (TAC); the amino acid at position 365 is mutated from the original methionine (ATG) to alanine (GCG), and its sequence is shown in SEQ ID NO:

2.

2. A recombinant Aspergillus niger, It is characterized in that An Aspergillus niger strain in which the steroid 11α-hydroxylase gene and the steroid 16β-hydroxylase gene were deleted was obtained by using CRISPR-Cas9 technology, and the CYP5103B6T291Y / M365A mutant nucleotide sequence shown in SEQ ID NO.2 was constructed on a vector containing an AMA1 sequence, and expressed in an Aspergillus niger chassis strain by protoplast transformation, thereby obtaining an Aspergillus niger strain for efficiently preparing hydrocortisone.

3. The recombinant Aspergillus niger strain according to claim 2, It is characterized in that The hydroxylation specificity and yield of hydrocortisone generated by 11-deoxycortisol-21 acetate catalyzed by the recombinant Aspergillus niger are significantly improved.